Dementia drugs, particularly for Alzheimer's Disease, focus on symptom management rather than cure. Cholinesterase inhibitors like donepezil, rivastigmine, and galantamine enhance brain function by boosting acetylcholine levels, crucial for memory and learning. Another medication, memantine, an NMDA receptor antagonist, helps regulate glutamate activity, addressing symptoms such as confusion and memory loss. While these drugs can temporarily improve cognitive function and quality of life, they do not stop the progression of the disease. Ongoing research seeks to identify new therapeutic targets and more effective treatments that could potentially alter the course of dementia in the future.
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Make a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Health care professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Somali Red Crescent Society, Somalia
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States